Weili He
Guangzhou, 510630, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corrigendum to "Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction" Adv. Res. 69 (2025) 399-411].
Journal: Journal of advanced research
Published: October 09, 2025
Analysis of the tumor reactivity of autologous TILs and allogeneic γδ T cells via tumor organoid-immune cell coculture.
Journal: Journal of translational medicine
Published: July 28, 2025
Osteoclast precursor cell-derived Flot2 is a novel therapeutic target for bone loss diseases.
Journal: Pharmacological research
Published: January 23, 2025
Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction.
Journal: Journal of advanced research
Published: January 13, 2024
A comparative study of the efficacy of tamoxifen and Chinese patented medicine (Pingxiao capsules) in gynecomastia: A retrospective cohort study.
Journal: Andrologia
Published: August 20, 2022
A retrospective cohort study of tamoxifen versus surgical treatment for ER-positive gynecomastia.
Journal: BMC endocrine disorders
Published: August 19, 2022
The Vacuum-Assisted Breast Biopsy System is an Effective Strategy for the Treatment of Gynecomastia.
The Vacuum-Assisted Breast Biopsy System is an Effective Strategy for the Treatment of Gynecomastia.
Journal: Aesthetic plastic surgery
Published: July 08, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026